Hydrofarm (HYFM) faces Nasdaq equity shortfall and $1 bid-price deficiency
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Hydrofarm Holdings Group, Inc. reports that Nasdaq has determined the company failed to regain compliance with the $2.5 million minimum stockholders’ equity requirement and has also notified it of noncompliance with the $1 minimum bid price rule.
The company has requested a hearing before a Nasdaq Hearing Panel, which temporarily halts delisting actions while the process and any extension period proceed. It has 180 calendar days to restore a closing bid price of at least $1 for ten consecutive business days and is considering options to regain compliance with both requirements.
Positive
- None.
Negative
- Failure to meet Nasdaq equity extension: Nasdaq determined Hydrofarm did not satisfy the terms of its previously granted extension to regain compliance with the $2.5 million minimum stockholders’ equity requirement, increasing the risk of eventual delisting from The Nasdaq Capital Market.
- New minimum bid-price deficiency: The company also fell out of compliance with Nasdaq’s $1 minimum bid price rule after 30 consecutive business days below this level, triggering a 180‑day cure period and adding another listing-standard hurdle.
Insights
Nasdaq equity and bid-price failures raise delisting risk for Hydrofarm.
Hydrofarm has not met Nasdaq’s $2.5 million minimum stockholders’ equity rule and has now fallen below the $1 minimum bid price for 30 consecutive business days. Nasdaq’s determination letter follows an earlier extension that the company did not satisfy.
The company requested a hearing before a Nasdaq Hearing Panel, which stays immediate delisting while the appeal is considered. Separately, Nasdaq granted a 180‑day window for bid‑price compliance, requiring at least ten consecutive days with a closing bid at or above $1.
Actual outcomes depend on operational performance, equity levels, market valuation and any actions the company may take to restore compliance. Delisting would shift trading to a less liquid market, so future Exchange Act filings explaining equity changes, capital measures or corporate actions will be important to understand how listing status evolves.
8-K Event Classification
Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
1 item
Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Securities
The company received a delisting notice or transferred its listing to a different exchange.
Key Figures
Minimum stockholders’ equity requirement: $2.5 million
Minimum bid price requirement: $1 per share
Bid-price compliance period: 180 calendar days
+2 more
5 metrics
Minimum stockholders’ equity requirement
$2.5 million
Nasdaq Capital Market Listing Rule 5550(b)(1) threshold for Hydrofarm
Minimum bid price requirement
$1 per share
Nasdaq Listing Rule 5550(a)(2) threshold breached for 30 consecutive business days
Bid-price compliance period
180 calendar days
Time allowed to regain $1 minimum bid price under Nasdaq rules
Bid-price cure condition
10 consecutive business days
Required period with closing bid at or above $1 to regain compliance
Appeal deadline
July 9, 2026
Date by which Hydrofarm could request Nasdaq Hearing Panel review
Key Terms
Listing Rule 5550(b)(1), minimum stockholders’ equity requirement, Listing Rule 5550(a)(2), minimum bid price requirement, +2 more
6 terms
Listing Rule 5550(b)(1) regulatory
"not in compliance with the $2.5 million minimum stockholders’ equity requirement ... under Listing Rule 5550(b)(1)"
Listing Rule 5550(b)(1) is a Nasdaq listing standard that sets a minimum share price requirement companies must meet to stay listed on the exchange. It matters to investors because falling below that threshold can trigger delisting procedures, which often reduce a stock’s visibility, trading liquidity and value; think of it like a minimum score needed to remain in a sports league — miss it and you risk being dropped until you improve.
minimum stockholders’ equity requirement financial
"not in compliance with the $2.5 million minimum stockholders’ equity requirement for continued listing"
Listing Rule 5550(a)(2) regulatory
"not in compliance with the minimum bid price requirement ... under Listing Rule 5550(a)(2)"
Listing Rule 5550(a)(2) is a Nasdaq listing standard that sets a minimum share-price requirement for securities to be listed or to remain listed on the Nasdaq Capital Market. It matters to investors because falling below that minimum can trigger delisting reviews or increased volatility, much like a safety bar on a ride — if a stock can’t meet the height requirement, it risks being removed from the exchange, which can reduce liquidity and access for buyers and sellers.
minimum bid price requirement market
"not in compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market"
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.
Nasdaq Hearing Panel regulatory
"request an appeal of this determination at a hearing before the Nasdaq Hearing Panel"
A Nasdaq hearing panel is a group of independent reviewers who decide whether a publicly listed company has broken the exchange’s rules and what penalties, if any, should apply. Think of it like a neighborhood committee that reviews complaints and can impose fines, require fixes, or remove a member; for investors, the panel’s rulings can affect whether a stock keeps trading, faces suspension, or suffers reputational and price impact.
forward-looking statements regulatory
"contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
FAQ
What Nasdaq rules is Hydrofarm (HYFM) currently not complying with?
Hydrofarm is not complying with Nasdaq’s $2.5 million minimum stockholders’ equity requirement under Listing Rule 5550(b)(1) and the $1 minimum bid price requirement under Listing Rule 5550(a)(2), creating a risk that its shares could eventually be delisted.
What did Nasdaq’s determination letter say about Hydrofarm (HYFM)?
Nasdaq’s determination letter informed Hydrofarm that it did not meet the terms of the earlier extension to regain compliance with the equity rule. This allows Hydrofarm to request a hearing, but also moves the company closer to potential delisting if compliance is not restored.
How is Hydrofarm (HYFM) responding to Nasdaq’s equity noncompliance?
Hydrofarm requested a hearing before a Nasdaq Hearing Panel by the stated deadline, which stays further delisting action during the hearing process and any granted extension period. The company states it is considering all options to regain compliance with the equity requirement.
What is Hydrofarm’s deadline to fix the Nasdaq bid-price issue?
Under Nasdaq’s bid-price rule, Hydrofarm has a 180 calendar day compliance period. If at any time during this window the closing bid price is at least $1 for ten consecutive business days, Nasdaq will provide written confirmation that the company has regained compliance.
Could Hydrofarm (HYFM) be delisted from Nasdaq?
Delisting is a possible outcome if Hydrofarm fails to regain compliance with Nasdaq’s equity and bid-price requirements and does not secure sufficient relief from the Hearing Panel. The company notes there is no assurance it will regain or maintain compliance with all listing rules.